Close Menu

NEW YORK – Startup 54gene, which plans to focus on genomics of Africans, said this week that it has raised $4.5 million in seed funding.

Investors in the firm include Y Combinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC, Pioneer Fund, and Techammer.

The company, founded earlier this year and based in San Francisco and in Lagos, Nigeria, plans to address the fact that only 2 percent of human DNA samples used in pharmaceutical research today are from Africans or those of African ancestry, who have much greater genetic diversity than other human populations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.